International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

The Use of Optical Coherence Tomography for the Detection of Ocular Toxicity by Ethambutol in Newly Diagnosed Tuberculosis Patients

Dr. Aishwary Singh, Dr. Shubham Prakash Singh, Dr. Uzma Pervin, Dr. Aakash Makkar, Dr. Somesh Ranjan, Dr. Sarita Aggarwal

PG 3rd Year, Department of Ophthalmology, Santosh Deemed to be University, Ghaziabad, Uttar Pradesh 201009, India; MBBS, MS (Ophthalmology), Associate Professor, Department of Ophthalmology, Santosh Deemed to be University, Ghaziabad, Uttar Pradesh 201009, India

Article Information

Volume / Issue7 / 3 (July-August 2026)
Pages175-182
AccessOpen Access

Publication Timeline

  • Received09 June 2026
  • Accepted08 July 2026
  • Published

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Background: Ethambutol is a cornerstone drug in first-line antitubercular therapy but is associated with optic neuropathy, which can lead to irreversible visual loss if not detected early. Conventional clinical examinations often fail to detect early or subclinical optic nerve damage.
Objective: To evaluate the role of spectral-domain optical coherence tomography (SD-OCT) in detecting early structural optic nerve changes in newly diagnosed tuberculosis patients receiving ethambutol therapy and to correlate these changes with functional visual parameters.
Materials and Methods: This hospital-based prospective observational study was conducted at Santosh Medical College and Hospital, Ghaziabad, between 2024 and 2026. Ninety-one newly diagnosed tuberculosis patients (182 eyes) aged ≥18 years, receiving ethambutol as part of first-line antitubercular therapy, were enrolled. Comprehensive ophthalmic evaluation and SD-OCT-based retinal nerve fiber layer (RNFL) analysis were performed at baseline and at 2, 4, and 6 months. Functional assessments included best-corrected visual acuity (BCVA), color vision, and automated visual fields. Statistical analysis was performed using Stata MP-17.
Results: Progressive RNFL thinning was observed with increasing duration of ethambutol therapy, becoming significant after 3–4 months and pronounced at 6 months (mean RNFL loss: RE 6.6 ± 3.2 µm; LE 6.7 ± 3.4 µm; p < 0.001). Inferior and temporal quadrants were most frequently affected. Structural RNFL loss correlated strongly with BCVA, color vision defects, and visual field indices. Subclinical toxicity detectable only on OCT ± visual fields was observed in 17% of eyes, while clinical toxicity was seen in 7.7%.
Conclusion: SD-OCT is a sensitive, objective, and reliable modality for early detection of ethambutol-induced optic neuropathy. Structural RNFL changes precede functional visual impairment, emphasizing the need for routine OCT monitoring during ethambutol therapy to prevent irreversible visual loss.
 

Keywords

EthambutolOptical Coherence TomographyTuberculosisOptic NeuropathyRNFLOcular Toxicity

References

  1. World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization; 2013. [Google Scholar][Crossref]
  2. Menon V, Jain D, Saxena R, Sood R. Prospective evaluation of visual function for early detection of ethambutol toxicity. Br J Ophthalmol. 2009;93(9):1251-4. doi:10.1136/bjo.2008.148502. [Google Scholar][Crossref]
  3. Sen S, Mandal S, Banerjee M, Gk R, Saxena A, Aalok SP, et al. Ethambutol-induced optic neuropathy: functional and structural changes in the retina and optic nerve. Semin Ophthalmol. 2022;37(6):730 -9. doi:10.1080/08820538.2022.2085517. [Google Scholar][Crossref]
  4. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science. 1991;254(5035):1178-81. [Google Scholar][Crossref]
  5. Lee EJ, Kim SJ, Choung HK, Kim JH, Yu YS. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol. 2008;28(4):269-77. doi:10.1097/WNO.0b013e31818e3c6b. [Google Scholar][Crossref]
  6. Pavan Taffner BM, Mattos FB, Cunha MCD, Saraiva FP. The use of optical coherence tomography for the detection of ocular toxicity by ethambutol. PLoS One. 2018;13(11). doi:10.1371/journal.pone.0204655. [Google Scholar][Crossref]
  7. Chen SC, Lin MC, Sheu SJ. Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan. Kaohsiung J Med Sci. 2015;31(7):358-62. doi:10.1016/j.kjms.2015.05.004. [Google Scholar][Crossref]
  8. Chai SJ, Foroozan R. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy. Br J Ophthalmol. 2007;91(7):895 -7. doi:10.1136/bjo.2006.113118. [Google Scholar][Crossref]
  9. Chamberlain PD, Sadaka A, Berry S, Lee AG. Ethambutol optic neuropathy. Curr Opin Ophthalmol. 2017;28(6):545-51. doi:10.1097/ICU.0000000000000416. [Google Scholar][Crossref]
  10. Han J, Byun MK, Lee J, Han SY, Lee JB, Han SH. Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2015;253(12):2293 -9. doi:10.1007/s00417-015-3150-8. [Google Scholar][Crossref]
  11. Sitaula S, Sitaula R, Thapa S, Chapagain S, Dahal HN. Ocular toxicity among patients taking anti-tubercular treatment. Nepal J Ophthalmol. 2022;14(2). doi:10.3126/nepjoph.v14i2.42455. [Google Scholar][Crossref]
  12. Panchal K, Solu TM. Ocular side effects of anti-tubercular drugs in patients receiving anti-TB treatment at tertiary care center. Indian J Ophthalmol? 2020. doi:10.18231/j.ijooo.2020.042. [Google Scholar][Crossref]
  13. Kim KL, Park SP. Visual function test for early detection of ethambutol-induced ocular toxicity at the subclinical level. Cutan Ocul Toxicol. 2016;35(3):228-32. doi:10.3109/15569527.2015.1079784. [Google Scholar][Crossref]
  14. Saxena R, Singh D, Phuljhele S, Kalaiselvan V, Karna S, Gandhi R, et al. Ethambutol expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy. Indian J Ophthalmol. 2021;69(12):3734 -9. doi:10.4103/ijo.IJO_3746_20. [Google Scholar][Crossref]
  15. Jin K, Lee J, Rhiu S, Choi D. Longitudinal evaluation of visual function and structure for detection of subclinical ethambutol-induced optic neuropathy. PLoS One. 2019;14. doi:10.1371/journal.pone.0215297. [Google Scholar][Crossref]
  16. Varan G, Hazar L, Sahin A. Evaluation of the long-term effect of ethambutol usage on the retinal nerve fiber layer using spectral-domain optical coherence tomography. Beyoglu Eye J. 2020;5(2):118 -21. doi:10.14744/bej.2020.96658. [Google Scholar][Crossref]
  17. Konnakkodan SM, Solomon CB, Prabhu PB, Kumar AA. Optic nerve head-retinal nerve fiber layer analysis with spectral-domain optical coherence tomography of ethambutol-induced ocular toxicity in patients on a daily regimen of anti-tubercular therapy. Kerala J Ophthalmol. 2021;33(3):291-8. [Google Scholar][Crossref]
  18. Mandal S, Saxena R, Dhiman R, Mohan A, Padhy SK, Phuljhele S, et al. Prospective study to evaluate incidence and indicators for early detection of ethambutol toxicity. Br J Ophthalmol. 2021;105(7):1024-8. doi:10.1136/bjophthalmol-2020-316897. [Google Scholar][Crossref]
  19. Syaputra M, Nusanti S. Diagnostic value of optical coherence tomography and electroretinogram in early detection of ethambutol-induced optic neuropathy. Ophthalmologica Indonesiana. 2021;47(2). doi:10.35749/journal.v47i2.100309. [Google Scholar][Crossref]
  20. Sabhapandit S, Gella V, Shireesha A, Thankachan L, Ismail M, Rao R, et al. Ethambutol optic neuropathy in the extended anti-tubercular therapy regime: a systematic review. Indian J Ophthalmol. 2023;71:729-35. doi:10.4103/ijo.ijo_1920_22. [Google Scholar][Crossref]
  21. Chaitanuwong P, Srithawatpong S, Ruamviboonsuk P, Apinyawasisuk S, Watcharapanjamart A, Moss H. Incidence, risk factors and ophthalmic clinical characteristics of ethambutol-induced optic neuropathy: 7-year experience. Front Ophthalmol. 2023;3:1152215. doi:10.3389/fopht.2023.1152215. [Google Scholar][Crossref]
  22. Misra A, Sethi SK, Singh P. Visual evoked potential as an early assessment tool in ethambutol-induced toxic optic neuropathy during treatment of tuberculosis. Indian J Clin Exp Ophthalmol. 2024;10(2):373 -8. doi:10.18231/j.ijceo.2024.066. [Google Scholar][Crossref]
  23. Kambella SV, Thammali L, Pallamreddy S, Bharathi P. Retinal nerve fiber layer thickness and central macular thickness in patients with ethambutol optic neuropathy: a prospective analysis by optical coherence tomography. Delta J Ophthalmol. 2025;26(2):141 -9. doi:10.4103/djo.djo_78_24. [Google Scholar][Crossref]
  24. Sarkar S, Thakur SKD, Dhua A, Sarkar AD, Khatua P. A prospective study on the effect of ethambutol on retinal nerve fiber layer thickness and central macular thickness. J Clin Ophthalmol Res. 2025;13(3):302-6. doi:10.4103/jcor.jcor_170_24. [Google Scholar][Crossref]
  25. Singh P, Karkhur S, Verma V. Ethambutol-induced optic neuropathy: a retrospective study of incidences and risk factors. Cureus. 2025;17(2). doi:10.7759/cureus.79160. [Google Scholar][Crossref]
  26. Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J. 2006;12(1):56-60. [Google Scholar][Crossref]
  27. Talbert-Estlin KA, Sadun AA. Risk factors for ethambutol optic toxicity. Int Ophthalmol. 2010;30(1):63-72. [Google Scholar][Crossref]
  28. Wang MY, Sadun AA. Drug-related mitochondrial optic neuropathies. J Neuroophthalmol. 2013;33(2):172-8. [Google Scholar][Crossref]
  29. Yang HK, Park MJ, Lee JH, Lee CT, Park JS, Hwang JM. Incidence of toxic optic neuropathy with low-dose ethambutol. Int J Tuberc Lung Dis. 2016;20(2):261-4. doi:10.5588/ijtld.15.0465. International Journal of Medical and All Body Health Research www.allmedicaljournal.com [Google Scholar][Crossref]
  30. Fraunfelder FW, Sadun AA, Wood T. Update on ethambutol optic neuropathy. Expert Opin Drug Saf. 2006;5(5):615-8. doi:10.1517/14740338.5.5.615. [Google Scholar][Crossref]
  31. Zoumalan CI, Agarwal M, Sadun AA. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2005;243(5):410 -4. doi:10.1007/s00417-004-1073-7. [Google Scholar][Crossref]
  32. Zoumalan CI, Sadun AA. Optical coherence tomography can monitor reversible nerve fiber layer changes in ethambutol-induced optic neuropathy. Br J Ophthalmol. 2007;91(6):839-40. doi:10.1136/bjo.2006.113118. [Google Scholar][Crossref]
  33. Grzybowski A, Zülsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015;93(5):402 -10. doi:10.1111/aos.12607. [Google Scholar][Crossref]
  34. Chen HY, Lai SW, Muo CH, Chen PC, Wang IJ. Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan. Br J Ophthalmol. 2012;96(10):1368-71. doi:10.1136/bjophthalmol-2012-301710. [Google Scholar][Crossref]
  35. Ezer N, Benedetti A, Darvish-Zargar M, Menzies D. Incidence of ethambutol-related visual impairment during treatment of active tuberculosis. Int J Tuberc Lung Dis. 2013;17(4):447 -55. doi:10.5588/ijtld.12.0707. [Google Scholar][Crossref]

How to Cite

Singh, A., Singh, S. P., Pervin, U., Makkar, A., Ranjan, S., & Aggarwal, S. (2026). The Use of Optical Coherence Tomography for the Detection of Ocular Toxicity by Ethambutol in Newly Diagnosed Tuberculosis Patients. International Journal of Medical and All Body Health Research, 7(3), 175-182. https://doi.org/10.54660/IJMBHR.2026.7.3.175-182

Singh, Aishwary, et al. "The Use of Optical Coherence Tomography for the Detection of Ocular Toxicity by Ethambutol in Newly Diagnosed Tuberculosis Patients." International Journal of Medical and All Body Health Research, vol. 7, no. 3, 2026, pp. 175-182. https://doi.org/10.54660/IJMBHR.2026.7.3.175-182.

Singh, A., Singh, S. P., Pervin, U., Makkar, A., Ranjan, S. and Aggarwal, S. (2026) 'The Use of Optical Coherence Tomography for the Detection of Ocular Toxicity by Ethambutol in Newly Diagnosed Tuberculosis Patients', International Journal of Medical and All Body Health Research, 7(3), pp. 175-182. doi: 10.54660/IJMBHR.2026.7.3.175-182.

Singh A, Singh SP, Pervin U, Makkar A, Ranjan S, Aggarwal S. The Use of Optical Coherence Tomography for the Detection of Ocular Toxicity by Ethambutol in Newly Diagnosed Tuberculosis Patients. International Journal of Medical and All Body Health Research. 2026;7(3):175-182. doi:10.54660/IJMBHR.2026.7.3.175-182

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.